Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

Sarepta Therapeutics announced late Friday evening that it will not comply with the Food and Drug Administration's ...

Drugmaker Sarepta Therapeutics says it won't comply with a request from U.S. regulators to halt all shipments of its gene ...

Sarepta Therapeutics refuses the FDA request to halt its gene therapy shipments following a third patient death, challenging ...

In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...

Suspending the shipment of military aid to Ukraine was a unilateral step by Defense Secretary Pete Hegseth, according to four sources.

Robbins LLP Files Class Action Against Sarepta Therapeutics Over ELEVIDYS Deaths. Robbins LLP has filed a securities class action on behalf of investors who purchased shares of Sarepta Therapeutics, ...

The U.S. Department of State has confirmed the delivery of other types of weapons to Ukraine, aside from the previously halted shipments of missile armaments. At the same time, the imposed ...

A Supreme Court judge in Albany has temporarily restored the HALT Act, the policy that limits solitary confinement which prison guards rallied against during the statewide strikes.

Thereafter, on June 15, 2025, Sarepta disclosed that a second patient had died of acute liver failure following treatment with ELEVIDYS, leading to Sarepta suspending shipment of ELEVIDYS for ...

US officials on Wednesday downplayed a White House announcement that Washington was pausing some weapons shipments to Ukraine, after the war-battered country was caught off-guard and appealed for ...